Sarah B. Noonberg Protagonist Therapeutics, Inc (PTGX) insider trading activity

PTGX Quotes by TradingView

Sarah B. Noonberg is Director of Protagonist Therapeutics, Inc. Currently has a direct ownership of 0 shares of PTGX, which is worth approximately $0. The most recent transaction as insider was on Feb 11, 2021, when has been sold 3,700 shares (Common Stock) at a price of $25.09 per share, resulting in proceeds of $92,833. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Sarah B. Noonberg Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 11 2021
SELL
Open market or private sale
$92,833 $25.09 p/Share
3,700 Reduced 100.0%
0 Common Stock
Feb 11 2021
BUY
Grant, award, or other acquisition
$25,826 $6.98 p/Share
3,700 Added 50.0%
3,700 Common Stock
Feb 10 2021
SELL
Open market or private sale
$120,931 $25.73 p/Share
4,700 Reduced 100.0%
0 Common Stock
Feb 10 2021
BUY
Grant, award, or other acquisition
$32,806 $6.98 p/Share
4,700 Added 50.0%
4,700 Common Stock

Also insider at

PRTA
PROTHENA CORP PUBLIC LTD CO Healthcare
Chief Medical Officer
NLTX
Neoleukin Therapeutics, Inc. Healthcare
Director
MRNS
MARINUS PHARMACEUTICALS, INC. Healthcare
MGX
Metagenomi, Inc.
Chief Medical Officer
SBN

Sarah B. Noonberg

Director
South San Francisco, CA

Track Institutional and Insider Activities on PTGX

Follow Protagonist Therapeutics, Inc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PTGX shares.

Notify only if

Insider Trading

Get notified when an Protagonist Therapeutics, Inc insider buys or sells PTGX shares.

Notify only if

News

Receive news related to Protagonist Therapeutics, Inc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PTGX